Lee Research Program
Personnel
- Jason T. Lee, MD: Principal Investigator
SAPPHIRE: Stenting and Angioplasty with Protection in Patients at High-Risk for Endartecrectomy / Cordis
Principal Investigator Jason T. Lee, MD Purpose of Research The purpose of this post approval study is to collect further data or information on the safety and effectiveness of the FDA approved Cordis PRECISE Nitinol Stent System and the Cordis ANGIOGUARD XP/RX Emboli Capture Guidewire (ECGW). Subjects will be followed in the study for 30 days after the procedure. Basic Eligibility Criteria 1) Patients have been diagnosed with carotid artery stenosis who are at high risk for carotid endarterectomy and are candidates for percutaneous angioplasty and stenting, and
2) Patients with symptomatic >50% carotid stenosis or asymptomatic >80% carotid stenosis.
Evaluation of the GORE EXCLUDER Iliac Branch Endoprosthesis for the Treatment of Common Iliac Artery Aneurysms or Aorto-iliac Aneurysms (IBE 12-04) / Gore
Principal Investigator Jason T. Lee, MD Purpose of Research
The purpose of this research study is to determine the safety and effectiveness of the GORE EXCLUDER Iliac Branch Endoprosthesis when used for treatment of Common Iliac Artery Aneurysms (CIAA) or Aorto-iliac Aneurysms.
Basic Eligibility Criteria
1) Common iliac to be treated must have a maximum diameter ≥ 25 mm
2) Able to comply with protocol requirements including following-up
3) Age > 21 years
Contact Information
Edward Finn, Clinical Trials Manager
650-724-6167
efinn@stanford.edu
Contact Information
Edward Finn, Clinical Trials Manager
650-724-6167
efinn@stanford.edu